Medical Imaging

Freenome Partners with Siemens Healthineers for Breast Cancer Research


— Collaboration leverages imaging, diagnostic and multiomic expertise to identify new, significant biomarkers to improve the detection of breast cancer Excerpt from the Press Release: SOUTH SAN FRANCISCO, Calif., Dec. 1, 2021 /PRNewswire/ — Freenome, a privately held biotech company, announced a partnership with Siemens Healthineers to collaborate in multiomics and radiomic breast cancer diagnostics to identify…

Read More

HeartFlow Announces Enrollment of First Three Patients in FUSION Trial


Excerpt from the Press Release: National Health Care Institute of the Netherlands-supported study to evaluate role of the HeartFlow Analysis in reducing unnecessary invasive procedures REDWOOD CITY, Calif.–(BUSINESS WIRE)–HeartFlow, Inc., the leader in revolutionizing precision heart care, today announced that physicians at Erasmus MC Hospital (Rotterdam NL) have enrolled the first three patients in the…

Read More

Stanford AI center’s new platform grants worldwide access to free medical imaging datasets


Excerpt from the Press Release: Stanford University is expanding its free repository of imaging and healthcare datasets for artificial intelligence researchers around the globe. The California school’s Center for Artificial Intelligence in Medicine and Imaging first opened in 2019 and has since amassed annotated datasets for more than 1 million images. AIMI is now partnering…

Read More

Elucida Oncology Submits IND Application for ELU-001 for the Treatment of Cancers Overexpressing Folate-Receptor Alpha


Excerpt from the Press Release: MONMOUTH JUNCTION, N.J., July 19, 2021 (GLOBE NEWSWIRE) — Elucida Oncology, a biotechnology company pioneering the next frontier in targeted cancer therapy, announced today that it has submitted an Investigational New Drug Application (IND) to the U.S. Food and Drug Administration (FDA) for a Phase 1/2 clinical trial of ELU-001,…

Read More

Celsion Reports Data Safety Monitoring Board Recommendation to Continue Dosing Patients in the Phase II Portion of the OVATION 2 Study with GEN-1 in Advanced Ovarian Cancer


Excerpt from the Press Release: LAWRENCEVILLE, N.J., July 19, 2021 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ: CLSN), a clinical-stage company focused on DNA-based immunotherapy and next-generation vaccines, today announced that following a pre-planned interim safety review of 55 as treated patients randomized in the Phase I/II OVATION 2 Study with GEN-1 in advanced (Stage III/IV) ovarian cancer, the Data…

Read More

Leap Therapeutics and Flagship Biosciences Develop Image Analysis RNAscope Assay for Prospective Trial Enrollment


Excerpt from the Press Release: CAMBRIDGE, Mass. and WESTMINSTER, Colo., May 12, 2021 /PRNewswire/ — Leap Therapeutics (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, andFlagship Biosciences, the leader in data-centric pathology and tissue analysis, today announced that they have developed an image analysis RNAscope® assay that is being used successfully for prospective patient enrollment in a clinical trial.…

Read More

RSIP Vision Launches an Advanced AI-Based Tool for Prostate MRI and Ultrasound Registration Enabling Precise Navigation in Key Procedures


Excerpt from the Press Release: TEL AVIV, Israel & SAN JOSE, Calif.–(BUSINESS WIRE)–RSIP Vision, an experienced leader in driving innovation for medical imaging through advanced AI and computer vision solutions, announced today a new prostate MRI-to-ultrasound registration tool. The tool’s fully automated, deep learning-based capabilities provide a robust method that utilizes a registered MRI scan…

Read More

Ultrasound May Damage Coronavirus Structure


Excerpt from the Article: Ultrasound could be a disruptive tool in the fight against COVID-19, according to new research. A recent study published in the Journal of the Mechanics and Physics of Solids has found that the structure of the coronavirus may be vulnerable to the vibrations of an ultrasound with frequencies commonly used in…

Read More

CT Colonography Identifies Pre-Malignant Polyps with Machine-Based Learning Algorithm


Excerpt from the Article: Implementing a radiomics-based machine learning algorithm allows CT colonography to differentiate between benign and pre-cancerous polyps with high sensitivity and specificity. Applying a machine-based learning algorithm to images captured with CT colonography makes it possible for radiologists to differentiate between benign and pre-malignant colorectal polyps. In industrialized countries across the globe,…

Read More

4D-Fueled AI with DCE-MRI Improves Breast Lesion Characterization


Excerpt from the Article: Radiologists can classify breast lesions more accurately if they use artificial intelligence algorithms fueled by 4D data captured with dynamic contrasted-enhanced MRI (DCE-MRI), new research has found. In a study published on Feb. 24 in Radiology: Artificial Intelligence, investigators from the University of Chicago outlined their method for fusing the 4D…

Read More